Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
INGNthis companyInogen, Inc.	$5.92	-7.91×	0.95×	0.52×	-35.43×	-203.4%	47.6%	-8.7%	-6.5%	-11.8%	-12.3%	-11.8%	0.09×	31.71×	0×	3.12×	0.0%	3	1.53	2	C
CATXPerspective Therapeutics, Inc.	$0.82	-1.96×	0.98×	0×	-1.74×	-87.1%	0.0%	0.0%	0.0%	-49.8%	-47.2%	-46.9%	0.02×	0.27×	-302.03×	5.17×	0.0%	3	-0.5	3	B-
HCATHealth Catalyst, Inc.	$1.52	-0.94×	0.68×	0.54×	-2.61×	-854.1%	33.5%	-11.6%	-57.2%	-72.4%	-8.6%	-0.1%	0.7×	-1.09×	-2.2×	1.89×	0.0%	5	-6.58	2	C+
HSDTSolana Company	$1.89	-1.56×	0.21×	10.59×	-1.43×	-610.6%	91.7%	-351.0%	-679.6%	-13.6%	-7.0%	-96.2%	0×	0.18×	-33.26×	10.33×	0.0%	3	1.76	1	C-
OMOutset Medical, Inc.	$4.37	-0.69×	0.44×	0.47×	-1.97×	-1772.3%	39.1%	-55.8%	-68.3%	-64.3%	-29.2%	-83.5%	0.8×	-1.06×	-4.78×	6.67×	0.0%	3	-6.08	2	C
QTRXQuanterix Corporation	$3.25	-2.53×	0.92×	1.96×	-2.98×	-844.7%	46.7%	-79.2%	-77.3%	-36.2%	-29.8%	-29.4%	0.13×	-0.08×	0×	2.84×	0.0%	2	-2.21	3	B
Peer median	—	-1.56×	0.68×	0.54×	-1.97×	-844.7%	39.1%	-55.8%	-68.3%	-49.8%	-29.2%	-46.9%	0.13×	-0.08×	-4.78×	5.17×	0.0%	3	-2.21	2	—